Media Summary: Imagine a simple outpatient procedure that could eliminate the need for a person with type one Gordon Weir, M.D., Co-Head of the Section on Islet Cell and Regenerative Biology at Joslin Patient voice Prof Mark Atkinson - Lessons from nPOD and the Human Islet Network Prof Natasha Rogers - Tailoring the ...

Jdrf Encapsulation Consortium - Detailed Analysis & Overview

Imagine a simple outpatient procedure that could eliminate the need for a person with type one Gordon Weir, M.D., Co-Head of the Section on Islet Cell and Regenerative Biology at Joslin Patient voice Prof Mark Atkinson - Lessons from nPOD and the Human Islet Network Prof Natasha Rogers - Tailoring the ... Presented by: Paul Laikind, Ph.D., President & CEO ViaCyte, a private company in the field of regenerative medicine, is currently ... What type are you? Be the type to make a difference and join thousands of Canadians in the TELUS Walk to Cure

Photo Gallery

JDRF Encapsulation Consortium
JDRF: Encapsulation
JDRF MinnDakotas 2014 Research Spotlight:  Encapsulation
ViaCyte’s chief scientific officer explains beta cell encapsulation
JDRF Research: Cell Therapies
JDRF Research Update: Cell Therapies for Type 1 Diabetes
JDRF Top Advances 2019
Type 1 Diabetes Disease Modifying Therapies & Treatment - JDRF Research Update
Encapsulating Islets: Big Hope in Small Packages
JDRF Symposium July 2023 Keynote Speakers Beta Cell Replacement and Regeneration
FNIH Biomarkers Consortium Beta Cell Project: A New Tool for Diabetes Research
ViaCyte - Company Presentation
View Detailed Profile
JDRF Encapsulation Consortium

JDRF Encapsulation Consortium

JDRF

JDRF: Encapsulation

JDRF: Encapsulation

Visit http://

JDRF MinnDakotas 2014 Research Spotlight:  Encapsulation

JDRF MinnDakotas 2014 Research Spotlight: Encapsulation

Imagine a simple outpatient procedure that could eliminate the need for a person with type one

ViaCyte’s chief scientific officer explains beta cell encapsulation

ViaCyte’s chief scientific officer explains beta cell encapsulation

JDRF

JDRF Research: Cell Therapies

JDRF Research: Cell Therapies

... the beta cells and so

JDRF Research Update: Cell Therapies for Type 1 Diabetes

JDRF Research Update: Cell Therapies for Type 1 Diabetes

Join

JDRF Top Advances 2019

JDRF Top Advances 2019

POWERFUL PROOF-OF-CONCEPT ...

Type 1 Diabetes Disease Modifying Therapies & Treatment - JDRF Research Update

Type 1 Diabetes Disease Modifying Therapies & Treatment - JDRF Research Update

JDRF

Encapsulating Islets: Big Hope in Small Packages

Encapsulating Islets: Big Hope in Small Packages

Gordon Weir, M.D., Co-Head of the Section on Islet Cell and Regenerative Biology at Joslin

JDRF Symposium July 2023 Keynote Speakers Beta Cell Replacement and Regeneration

JDRF Symposium July 2023 Keynote Speakers Beta Cell Replacement and Regeneration

Patient voice • Prof Mark Atkinson - Lessons from nPOD and the Human Islet Network • Prof Natasha Rogers - Tailoring the ...

FNIH Biomarkers Consortium Beta Cell Project: A New Tool for Diabetes Research

FNIH Biomarkers Consortium Beta Cell Project: A New Tool for Diabetes Research

The Biomarker

ViaCyte - Company Presentation

ViaCyte - Company Presentation

Presented by: Paul Laikind, Ph.D., President & CEO ViaCyte, a private company in the field of regenerative medicine, is currently ...

JDRF – I am Type 1

JDRF – I am Type 1

What type are you? Be the type to make a difference and join thousands of Canadians in the TELUS Walk to Cure